AimStep® Cotinine Nicotine Test CLIA Non-Waived

The AimStep® Cotinine Nicotine Test, product code 40014, is a high-quality diagnostic tool designed to detect cotinine, a metabolite of nicotine, in human specimens. This test is particularly valuable for healthcare providers, employers, and researchers who need to ascertain nicotine exposure and use. As a CLIA non-waived test, it is intended for use in certified laboratories and by professionals who meet specific regulatory requirements.

Key Features:

1. Accurate Detection:
   • Sensitivity: Capable of detecting cotinine levels with high accuracy, making it a reliable choice for identifying recent nicotine use.
   • Specificity: Designed to specifically identify cotinine, reducing the likelihood of false positives from other substances.
2. Professional Use:
   • CLIA Non-Waived: This classification indicates that the test must be performed in a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory. It ensures that the test is conducted by qualified personnel under regulated conditions to guarantee accuracy and reliability.
   • Laboratory-Grade: Suitable for use in medical labs, occupational health settings, and other professional environments that require precise nicotine testing.
3. Ease of Use:
   • Comprehensive Kit: The AimStep® Cotinine Nicotine Test includes all necessary components for conducting the test, simplifying the process for laboratory technicians.
   • Clear Instructions: Detailed instructions are provided, ensuring that the test can be administered correctly and consistently.
4. Rapid Results:
   • Quick Turnaround: Designed to deliver results in a timely manner, enabling prompt decision-making and follow-up actions based on the test outcomes.
5. Applications:
   • Smoking Cessation Programs: Useful for monitoring participants’ progress and adherence to smoking cessation protocols.
   • Occupational Health: Helps employers in industries with no-smoking policies to verify compliance among employees.
   • Clinical Research: Essential for studies investigating the effects of nicotine and tobacco use, providing reliable data for research findings.
   • Medical Assessments: Assists healthcare providers in diagnosing and managing conditions related to nicotine use, such as nicotine dependence and its associated health risks.
6. Regulatory Compliance:
   • Meets Industry Standards: Adheres to regulatory standards required for CLIA non-waived tests, ensuring high-quality and dependable results.